|
Jun 11
|
Regeneron (REGN), SNY Win FDA Nod for Kevzara Label Expansion
|
|
Jun 11
|
Is Sanofi SA (NASDAQ:SNY) the Best International Pharmaceutical Dividend Stock?
|
|
Jun 10
|
Moderna Says Combination Flu And Covid Vaccine Beat Out Rivals From Sanofi, GSK
|
|
Jun 10
|
GSK's RSV Vaccine Arexvy Gets FDA Nod for Adults 50-59 Years
|
|
Jun 6
|
Why Is Denali Therapeutics (DNLI) Up 15.6% Since Last Earnings Report?
|
|
May 15
|
Novavax Soars on Sanofi Deal: A Smart Buy or Post-Hype Correction?
|
|
May 15
|
Novavax Stock Just Tripled. Is It Too Late to Buy?
|
|
May 14
|
Sanofi to make €1bn biomanufacturing investment in France
|
|
May 14
|
Does Soaring Novavax Stock Have Enough Fuel to Climb Higher?
|
|
May 14
|
Trending tickers: Anglo American, GameStop, Vodafone, Greggs and Novavax
|
|
May 14
|
Fulcrum Therapeutics Inc (FULC) Q1 2024 Earnings Call Transcript Highlights: Strategic ...
|
|
May 14
|
Exploring Three Dividend Stocks On Euronext Paris
|
|
May 13
|
Barrow, Hanley, Mewhinney & Strauss Bolsters Portfolio with Strategic Additions in Q1 2024
|
|
May 13
|
Novavax (NVAX) Q1 Earnings Miss, Stock Soars on Sanofi Deal
|
|
May 13
|
Meme Mania is Back: Buy these 3 Stocks
|
|
May 13
|
Sanofi strikes $1bn deal with Fulcrum for muscular dystrophy drug
|
|
May 13
|
Sanofi (SNY), Regeneron's Dupixent sBLA Gets FDA Priority Tag
|
|
May 13
|
Fulcrum Therapeutics Q1 2024 Earnings: Misses Analyst Net Income Projections Amid Strategic ...
|
|
May 13
|
Sanofi gambles $80M on Fulcrum’s muscular dystrophy drug
|
|
May 13
|
France bags $16 billion investment boost from Microsoft, Pfizer and others as Macron goes on FDI charm offensive
|